Back to search

Article

Early Treatment of Interleukin-33 Can Attenuate Lupus Development in Young NZB/W F1 Mice

2020-10-12

Abstract excerpt

Interleukin-33 (IL-33), a member of the IL-1 cytokine family has been recently associated with the development of autoimmune diseases, including SLE. IL-33 is an alarmin and a pleiotropic cytokine that affects various types of immune cells via binding to its receptor, ST2. In this study, we determine the impact of intraperitoneal IL-33 treatments in young lupus, NZB/W F1 mice. Mice were treated from the age of 6 t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c5343e34-30c2-594c-8474-01736cfbeeac
DOI
10.20944/preprints202010.0246.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Early Treatment of Interleukin-33 Can Attenuate Lupus Development in Young NZB/W F1 MiceDOI 10.20944/preprints202010.0246.v1
Select a neighboring publication to make it the new centre.